Hewmun Lau

Hewmun Lau is a seasoned life science business professional with a diverse background encompassing venture, biotech, pharmaceutical industry, strategy consulting, and R&D.

Currently, Hewmun is serving as a Principal at Broadview Ventures, a fund dedicated to mission-investing in Cardiovascular Disease and Stroke.

His prior experiences include various operational roles at Merrimack Pharmaceuticals, strategy consulting for biotech and large pharma clients on market opportunities, business development, and licensing.

Starting his career in biomedical lab research across academia and industry, Hewmun has cultivated a strong foundation in life sciences.

Educationally, Hewmun Lau holds an MBA from MIT Sloan School of Management, an M.S. from the Harvard-MIT Program in Health Sciences & Technology, and a B.S. from Brandeis University.

Additionally, he has been involved with organizations such as Basking Biosciences, Antag Therapeutics, Longview Ventures, Renovacor, and Merrimack in various capacities including board observer, principal, and director roles.

His professional journey also includes roles like Associate Director of Corporate Development, Senior Manager of Commercial Analytics, and Senior Consultant in Life Sciences Practices at reputable firms like Navigant.

Hewmun Lau's extensive experience and educational background position him as a versatile and accomplished professional in the life sciences and venture capital sectors.